Skip to Content

HLS Therapeutics Inc HLTRF

Morningstar Rating
$3.19 −0.65 (16.93%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

HLTRF is trading at a 56% discount.
Price
$3.18
Fair Value
$8.91
Uncertainty
Extreme
1-Star Price
$79.28
5-Star Price
$9.77
Economic Moat
Djjw
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if HLTRF is a good fit for your portfolio.

Trading Information

Previous Close Price
$3.84
Day Range
$3.193.19
52-Week Range
$2.606.35
Bid/Ask
$2.61 / $2.90
Market Cap
$102.31 Mil
Volume/Avg
2,843 / 5,428

Key Statistics

Price/Earnings (Normalized)
Price/Sales
1.64
Dividend Yield (Trailing)
2.74%
Dividend Yield (Forward)
3.53%
Total Yield
4.14%

Company Profile

HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company products include Clozaril, Vascepa, Trinomia, and Perseris. The company earns revenue in the form of product sales and royalties, out of which product sales contribute to the majority of the revenue. The company operates in Canada, the United States, and the Rest of the world.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
96

Comparables

Valuation

Metric
HLTRF
SCLX
000640
Price/Earnings (Normalized)
19.44
Price/Book Value
1.010.65
Price/Sales
1.644.790.61
Price/Cash Flow
9.005.11
Price/Earnings
HLTRF
SCLX
000640

Financial Strength

Metric
HLTRF
SCLX
000640
Quick Ratio
1.290.080.47
Current Ratio
1.720.110.68
Interest Coverage
−2.61−71.64
Quick Ratio
HLTRF
SCLX
000640

Profitability

Metric
HLTRF
SCLX
000640
Return on Assets (Normalized)
−7.63%−106.92%1.88%
Return on Equity (Normalized)
−15.14%3.47%
Return on Invested Capital (Normalized)
−4.71%−569.82%2.13%
Return on Assets
HLTRF
SCLX
000640
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AVhysl$90.3 Bil
MKKGY
Merck KGaA ADRMhqymmt$74.8 Bil
HLN
Haleon PLC ADRZccn$38.3 Bil
VTRS
Viatris IncQrbk$16.2 Bil
RDY
Dr Reddy's Laboratories Ltd ADRLbrzl$13.0 Bil
CTLT
Catalent IncKnkvkvq$10.6 Bil
PRGO
Perrigo Co PLCFtslt$4.4 Bil
CURLF
Curaleaf Holdings IncFzgk$3.9 Bil
PBH
Prestige Consumer Healthcare IncDshnp$3.5 Bil
GTBIF
Green Thumb Industries IncTcs$3.4 Bil

Sponsor Center